Aligos Therapeutics, Inc. (ALGS): SCHEDULE 13G filed May 15, 2026

Form type
SCHEDULE 13G
Filing date
May 15, 2026
Accession number
0001193125-26-226938
Filer
Aligos Therapeutics, Inc. (CIK 1799448)